ARCHIVES

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

This article is from The Cancer Letter archive.

Vol. 22 No. 29 | July 19, 1996

Download PDF Visit The Full Archive

Related Articles

Cancer Control Planning Completed, Going Through Final Review Process

July 12, 1974

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014